Plant-Based Vaccines Market Growth, Challenges, Analysis and Forecast 2018-2026
Plants are one of the most crucial sources to produce cost-efficient vaccine derivatives. Such vaccines reduce economic burden of infectious diseases in emerging economies and as they are produced on large-scale and cost less. A number of clinical trials are focused developing plant-based vaccines in therapeutic indications such as flu, influenza, Ebola virus, and dengue. These vaccines can be intravenous or can be administered orally. However, oral administration is preferred as it reduces the need of syringes and vaccines, which...
View full press release